Catalyst Wire Dossier Catalyst Wire Dossier

GANCICLOVIR SODIUM

GANCICLOVIR SODIUM · Fresenius Kabi USA, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GANCICLOVIR SODIUM, covering 2010-06-21 to 2024-02-15. Get the full timeline:

Most recent: FDA Approved: GANCICLOVIR — Supplemental Application (Pharmascience Inc.)

See pricing